A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat. (Q46774459)

25 December 2017

title

A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat. (English)

1 reference

25 December 2017

0 references

0 references

1 reference

Allan Flyvbjerg

1 reference

25 December 2017

Bieke F Schrijvers

1 reference

25 December 2017

Ronald G Tilton

series ordinal

1 reference

25 December 2017

Norbert H Lameire

series ordinal

1 reference

25 December 2017

An S De Vriese

series ordinal

1 reference

25 December 2017

language of work or name

English

0 references

publication date

25 October 2005

1 reference

25 December 2017

Nephrology Dialysis Transplantation

published in

1 reference

25 December 2017

volume

1 reference

25 December 2017

issue

1 reference

25 December 2017

page(s)

324-329

1 reference

25 December 2017

From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI217

Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI217

Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI217

The role of vascular endothelial growth factor (VEGF) in renal pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI217

Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI217

Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI217

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI217

Vasopeptidase inhibition prevents nephropathy in Zucker diabetic fatty rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI217

Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI217

In Zucker diabetic fatty rats plasma leptin levels are correlated with plasma insulin levels rather than with body weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI217

Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI217

Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI217

Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI217

Angiopoietin correlates with glomerular capillary loss in anti-glomerular basement membrane glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI217

21 January 2018

Identifiers

DOI

10.1093/NDT/GFI217

1 reference

25 December 2017

1 reference

25 December 2017